Skip to main content

Demetri George

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Demetri George as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

BPMC Blueprint Medicines Corp

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 30, 2022 (view filing)Jul 13, 2021352 daysLateDemetri GeorgeDirectorPPurchase+10$82.66+$826.6+0.2%5.82K after
Jun 30, 2022 (view filing)Mar 17105 daysLateDemetri GeorgeDirectorSSale−10$58.56−$585.6−0.2%5.81K after

Translate Bio, Inc.

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 14, 2021 (view filing)Sep 14Same dayDemetri GeorgeDirectorSSale−76.7K$0.00$0–0 afterDerivative3 lotsDuplicate filing
Sep 14, 2021 (view filing)Sep 14Same dayDemetri GeorgeDirectorSSale−76.7K$0.00$0–0 afterDerivative3 lots